Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDNA · against 243 other Healthcare companies of similar size
Ranked #10 of 244 · scores higher than 96% of peers
Bars: peers in each 10-point band of the profitability score28 peers with a profitability score of 90–100, including CDNA · Click a bar to see the companies
Mainly thanks to its return on invested capital, return on assets and operating margin, which are stronger than most Healthcare peers.
| Metric | CDNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 237 reported | 164.4% | 7.9% | 97% | 33% | |
| Operating marginHigher is better · 222 reported | 23.6% | 11.0% | 83% | 33% | |
| Return on assetsHigher is better · 233 reported | 20.8% | 2.9% | 97% | 33% | |
| Return on equityHigher is better · 228 reported | 29.5% | 7.5% | 94% | Context only | |
| Gross marginHigher is better · 251 reported | 70.6% | 48.5% | 78% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 6 | 2.5B USD | 98 | 79 | |
| 6 | 170.4B THB (≈$4.8B) | 98 | 70 | |
| 6 | 4.3B USD | 98 | 69 | |
| 10 | 40.3B SEK (≈$4.0B) | 97 | 79 | |
| 10 | 4.6B USD | 97 | 65 | |
| 12 | 62.5B SEK (≈$6.3B) | 96 | 60 | |
| 12 | 15.6B DKK (≈$2.3B) | 96 | 96 | |
| 14 | 5.8B USD | 95 | 68 | |
| 15 | 21.1B HKD (≈$2.7B) | 94 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score